tiprankstipranks
Molecular Partners AG (MLLCF)
OTHER OTC:MLLCF

Compare Molecular Partners AG (MLLCF) vs. Competitors

10 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Molecular Partners AG
$2.25
$162.30M
-2.03
14.93%
1 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF3.71
CHF1.13B
-5.11
188.13%
2 Buy
0 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
CHF16.44
CHF283.37M
-22.51
82.09%
1 Buy
0 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
CHF17.62
CHF236.41M
-4.43
29.57%
1 Buy
0 Hold
0 Sell
Moderate Buy
Xlife Sciences Ltd.
CHF22.90
CHF132.65M
4.27
16.75%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
MLLCF
Molecular Partners AG
4.85
0.63
14.93%
CH:IDIA
Idorsia Ltd
4.47
2.82
171.00%
CH:NWRN
Newron Pharmaceuticals SpA
13.62
6.34
87.09%
CH:SANN
Santhera Pharmaceuticals Holding
16.30
3.14
23.86%
CH:RLF
CH:XLS
Xlife Sciences Ltd.
23.00
3.10
15.58%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts